ONESOURCE
Onesource Specialty Pharma Limited (ONESOURCE) Stock Analysis
Onesource Specialty Pharma Limited develops and manufactures complex injectables and specialty formulations for regulated markets. It focuses on sterile and differentiated dosage forms for partners and own brands. The company targets high-barrier pharmaceutical niches. It is listed on Indian stock exchanges in the pharma sector.
Healthcare › Biotechnology
₹1,461.30
-3.10% 1W | -18.30% 52W
Market Cap
16.8k CR
P/E Ratio
–
52W High
₹1925
52W Low
₹1057
Div. Yield
0%
Beta
–
50 DMA
₹1562.6
200 DMA
₹1565.5
Profit Margin
-3.1%
Inst. Own.
33.3%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 56 | 73 | 292 | 334 | 393 | 426 | 327 | 376 | 290 | 428 | 449 |
| Expenses | 72 | 67 | 76 | 228 | 257 | 251 | 243 | 239 | 269 | 273 | 336 | 326 |
| Operating Profit | -39 | -10 | -3 | 64 | 77 | 142 | 183 | 88 | 106 | 17 | 92 | 123 |
| OPM % | -114% | -19% | -3.8% | 22% | 23% | 36% | 43% | 27% | 28% | 6% | 21% | 27% |
| Other Income | -32 | -74 | 3 | -1 | -1 | -94 | 2 | 2 | 3 | -2 | 2 | -0 |
| Interest | 25 | 26 | 20 | 42 | 45 | 46 | 33 | 27 | 34 | 38 | 23 | 31 |
| Depreciation | 18 | 20 | 20 | 68 | 68 | 69 | 68 | 68 | 70 | 70 | 72 | 72 |
| Profit before tax | -114 | -130 | -40 | -47 | -37 | -67 | 83 | -4 | 6 | -93 | -0 | 20 |
| Tax % | 0% | 0% | 0% | -88% | 12% | 4% | -19% | -96% | -83% | -5% | -1,630% | -23% |
| Net Profit | -114 | -130 | -40 | -6 | -42 | -69 | 98 | -0 | 10 | -89 | 5 | 25 |
| EPS in Rs | -6.02 | 8.61 | -0.02 | 0.92 | -7.74 | 0.40 | 2.18 |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 21 | 132 | 39 | 172 | 1,445 | 1,422 | 1,543 |
| Expenses | 93 | 229 | 199 | 254 | 978 | 1,117 | 1,204 |
| Operating Profit | -71 | -97 | -161 | -82 | 467 | 304 | 339 |
| OPM % | -334% | -73% | -415% | -48% | 32% | 21% | 22% |
| Other Income | 1 | 4 | -526 | -143 | -94 | 5 | 2 |
| Interest | 16 | 68 | 48 | 89 | 166 | 122 | 126 |
| Depreciation | 34 | 70 | 66 | 76 | 274 | 279 | 283 |
| Profit before tax | -121 | -231 | -800 | -391 | -68 | -92 | -67 |
| Tax % | 0% | -0% | 0% | 0% | -73% | -20% | |
| Net Profit | -121 | -231 | -800 | -391 | -18 | -74 | -49 |
| EPS in Rs | -1.57 | -6.44 | -4.24 | ||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 232.0% | 131.0% | – |
| Profit CAGR | 24.0% | 8.0% | – |
Shareholding Pattern
Promoters29.78%
FIIs18.69%
DIIs18.09%
Public33.42%
Promoters29.77%
FIIs19.39%
DIIs18.48%
Public32.34%
Promoters29.93%
FIIs19.24%
DIIs18.80%
Public32.01%
Promoters30.48%
FIIs17.50%
DIIs20.61%
Public31.40%
Promoters30.48%
FIIs19.19%
DIIs23.37%
Public26.95%
Promoters34.25%
FIIs18.54%
DIIs18.03%
Public29.17%
Promoters30.48%
FIIs17.50%
DIIs20.61%
Public31.40%
Promoters30.48%
FIIs19.19%
DIIs23.37%
Public26.95%
ONESOURCE
Holdings Analysis
Key strengths & risk signals
44
Overall
46
Fundamental
43
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
WEAK POSITION! Current price (1461.3) is below both moving averages.
WEAK YEAR! Stock declined 18.3% in the last year.
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.1% (1 week), 4.5% (1 month), 10.2% (3 months).
Strengths (3)
APPROACHING OVERSOLD! RSI at 35.9 - watch for reversal.
MID RANGE! Trading at 46.6% of 52W range - neutral zone.
MARKET ALIGNED! Beta of 1.00 - moves with the market.
Fundamental & Technical Analysis
44Overall
46Fundamental
43Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 232.4% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! -3.1% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 32.24% public ownership - moderate retail influence.
Stability Index
4/10
CAREFUL! Company does not have stable profit track. 2 loss-making quarters detected.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (1562.6) is below 200-day average (1565.5) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (1461.3) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
2/10
WEAK YEAR! Stock declined 18.3% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 16 up days, 14 down days. Avg volume on up days: 316,485 vs down days: 349,581. Ratio: 0.91x
RSI
4/5
APPROACHING OVERSOLD! RSI at 35.9 - watch for reversal.
52W Range
3/5
MID RANGE! Trading at 46.6% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.1% (1 week), 4.5% (1 month), 10.2% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
ONESOURCE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-07-31 | Concall PDF | |
| Q3FY262026-01-30 | Concall PDF | |
| Q2FY262025-11-18 | Concall PDF |
Peer Comparison
Healthcare · Biotechnology · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONESOURCE | ₹1,461.30 | – | -3.1% | 232.4% | – | -18.3% | 44 | BREAKDOWN | -12,600.0% | +443.5% | +37.2% | +4.9% |
| CONCORDBIO | ₹1,361.40 | 46.9 | 24.8% | 8.0% | 2.8% | -15.2% | 58 | BOUNCE FROM SUPPORT | +30.8% | -35.0% | +26.2% | -21.0% |
| BLUEJET | ₹514.60 | 38 | 26.5% | 9.4% | 15.7% | -17.2% | 73 | BOUNCE FROM SUPPORT | -14.1% | +21.8% | -17.4% | +24.9% |
| SUPRIYA | ₹847.60 | 34.4 | 22.7% | 21.2% | 32.5% | +23.4% | 83 | BOUNCE FROM SUPPORT | -31.0% | -67.7% | +30.7% | -31.4% |
| ZOTA | ₹1,324.10 | – | -17.0% | 56.7% | – | -7.9% | 57 | CONSOLIDATING UP | +204.9% | +207.0% | +67.6% | +6.4% |
| DCAL | ₹149.70 | 145.3 | 0.6% | 9.0% | 21.0% | -50.1% | 55 | BOUNCE FROM SUPPORT | -347.9% | -367.3% | -4.2% | -20.4% |
| PANACEABIO | ₹345.20 | – | -1.1% | 10.1% | – | -17.9% | 49 | BOUNCE FROM SUPPORT | -42.5% | +360.0% | +19.7% | +19.7% |
| HALEOSLABS | ₹1,563.70 | 29.9 | 4.9% | 0.3% | 14.7% | +41.6% | 69 | BREAKOUT | -38.1% | +550.0% | -11.6% | -2.9% |
Data from TradeAlone · Updated daily
